Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Email alerts

Application overview

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Research updates

Browse dated psilocybin research updates, separate publication dates from indexing dates, explore monthly literature and follow confirmed research alerts.

Free access · No subscription for research tools or data exports

Monthly literature view

44 records have publication dates within this month. Issue dates may be assigned ahead of online availability. Date-added activity and publication-date activity describe different events.

Psychedelics restructure information in the human brain2026-10-08 · bioRxiv · PREPRINT (not peer reviewed)Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patients2026-10-08 · Crossref · PublishedPilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation2026-10-08 · ClinicalTrials.gov · CLINICAL TRIALMusic for psilocybin therapy and the temporal arc of psychedelic experience2026-10-08 · Crossref · PublishedNeuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease2026-10-08 · ClinicalTrials.gov · CLINICAL TRIALAcute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice2026-10-07 · Europe PMC · PublishedPsilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression.2026-10-06 · PubMed · PublishedWhat Is Psilocybin?2026-10-06 · Crossref · PublishedPsilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial2026-10-06 · ClinicalTrials.gov · CLINICAL TRIALA Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder2026-10-06 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin-Assisted Therapy in Depressive Disorders: Clinical Governance, Safety, and Translational Challenges2026-10-05 · OpenAlex · PublishedCaution before canonisation: a clinical and implementation science perspective on psychedelics2026-10-05 · OpenAlex · PublishedPsychedelics Restructure the Global Workspace of Consciousness2026-10-05 · bioRxiv · PREPRINT (not peer reviewed)Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled Trial2026-10-05 · Europe PMC · PREPRINT (not peer reviewed)An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder.2026-10-05 · medRxiv · PREPRINT (not peer reviewed)Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment2026-10-05 · ClinicalTrials.gov · CLINICAL TRIALNeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy2026-10-05 · ClinicalTrials.gov · CLINICAL TRIALStudy participant perceptions of the relevance of therapist and study team personal psychedelic experience2026-10-03 · OpenAlex · PublishedPsychedelics and disorders of consciousness: a new frontier in neurotherapeutics.2026-10-03 · Europe PMC · PublishedSerotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH.2026-10-03 · Europe PMC · PublishedPsilocybin2026-10-03 · Crossref · PublishedThrough the PRISM: Reinterpreting Psychedelic Cognition as Motivational Reallocation2026-10-02 · PsyArXiv · PREPRINT (not peer reviewed)From regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapy2026-10-01 · Crossref · PublishedPlacebo, Psilocybin und der vermaledeite p-Wert2026-10-01 · Crossref · PublishedOpen-label, Single-arm fMRI Study Evaluating the Effects of Psilocybin on Craving in Nicotine Dependence.2026-10-01 · ClinicalTrials.gov · CLINICAL TRIALEmbeddedness under psilocybin.2026-10-01 · Europe PMC · PublishedThe New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy2026-10-01 · Crossref · PublishedF25. COMPARING PSILOCYBIN-ASSISTED THERAPY AND SSRIS IN THE TREATMENT OF LATE-LIFE DEPRESSION2026-10-01 · Crossref · PublishedMedCheck: Drugmakers Advance Psilocybin, Oral Pregnanolone for MDD, Plus FDA Approves Pediatric Tourette's Drug, and More2026-10-01 · Crossref · PublishedPsilocybin restores spatial memory but not fronto-hippocampal synchrony in a rat model of Alzheimer's disease2026-10-01 · Crossref · PublishedOregon’s State-Regulated Psilocybin Services: Early Real-World Safety Signals2026-10-01 · PsyArXiv · PREPRINT (not peer reviewed)Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.2026-10-01 · PubMed · PublishedMicrodosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics.2026-10-01 · PubMed · PublishedPsilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations.2026-10-01 · PubMed · PublishedPsilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia.2026-10-01 · PubMed · PublishedPsychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.2026-10-01 · PubMed · PublishedPRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment2026-10-01 · ClinicalTrials.gov · CLINICAL TRIALThe Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD2026-10-01 · ClinicalTrials.gov · CLINICAL TRIALChronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats2026-10-01 · Crossref · PublishedClinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.2026-10-01 · PubMed · PublishedLarge-Scale and Local Functional Connectivity Changes following Psilocybin Administration in Methamphetamine Use Disorder.2026-10-01 · Europe PMC · PublishedPrevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults2026-10-01 · Crossref · PublishedMescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats.2026-10-01 · PubMed · PublishedPsychedelic-induced hypomania and mania: a systematic review and meta-analysis.2026-10-01 · PubMed · Published

Recently indexed records

These entries are ordered by when they entered this index, not when the underlying study was conducted or published. A newly indexed old paper is not a new finding.

Psychedelics restructure information in the human brainIndexed 2026-10-09 01:23:29 · publication date 2026-10-08 · PREPRINT (not peer reviewed)Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patientsIndexed 2026-10-09 01:20:15 · publication date 2026-10-08 · PublishedFrom regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapyIndexed 2026-10-08 01:20:19 · publication date 2026-10-01 · PublishedPsilocybin-Assisted Therapy in Depressive Disorders: Clinical Governance, Safety, and Translational ChallengesIndexed 2026-10-07 01:20:24 · publication date 2026-10-05 · PublishedCaution before canonisation: a clinical and implementation science perspective on psychedelicsIndexed 2026-10-07 01:20:24 · publication date 2026-10-05 · PublishedPsilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression.Indexed 2026-10-07 01:20:05 · publication date 2026-10-06 · PublishedPsychedelics Restructure the Global Workspace of ConsciousnessIndexed 2026-10-06 01:20:25 · publication date 2026-10-05 · PREPRINT (not peer reviewed)Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled TrialIndexed 2026-10-06 01:20:24 · publication date 2026-10-05 · PREPRINT (not peer reviewed)An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder.Indexed 2026-10-06 01:20:24 · publication date 2026-10-05 · PREPRINT (not peer reviewed)Study participant perceptions of the relevance of therapist and study team personal psychedelic experienceIndexed 2026-10-05 01:20:20 · publication date 2026-10-03 · PublishedPsychedelics and disorders of consciousness: a new frontier in neurotherapeutics.Indexed 2026-10-05 01:20:04 · publication date 2026-10-03 · PublishedSerotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH.Indexed 2026-10-05 01:20:04 · publication date 2026-10-03 · PublishedThrough the PRISM: Reinterpreting Psychedelic Cognition as Motivational ReallocationIndexed 2026-10-03 01:24:34 · publication date 2026-10-02 · PREPRINT (not peer reviewed)Placebo, Psilocybin und der vermaledeite p-WertIndexed 2026-10-03 01:20:22 · publication date 2026-10-01 · PublishedU.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences.Indexed 2026-10-03 01:20:07 · publication date 2026-09-29 · Published